Research to beat rare diseases With Rare Disease Day 2017 approaching on February 28, we want to show our support. As…

This year at HIMSS17 We’ll be joining Intel in their booth #2661 to share insights on NGS-based genetic testing across a range…

QCI Interpret’s integration of highly curated knowledge and rules enables automation for much of the interpretation and reporting process for…

Research scientist Dr. Margarete Odenthal leads the translational molecular pathology group at University Hospital Cologne, putting new technologies through their…

Nearly 250 million people around the world are affected by rare diseases, which are typically genetic in nature. Their rarity…

Not too long ago, we returned from Oxford Global’s 8th Annual NGS Congress. While the majestic host city of London was…

Fast, accurate, and easy-to-use solutions encompassing variant identification and interpretation are critical for identifying pathogenic and disease driver variants successfully….

The Association for Molecular Pathology (AMP) 2016 Annual Meeting is held in Charlotte, North Carolina, from November 10-12. The theme of…

Clinical lab managers are constantly under pressure to do more with less. Launch more tests, review more information – in…

This post is authored by Gnosis Data Analysis I.K.E. New release We are proud to announce a new release for BioSignature…

We are thrilled to be part of the announcement at ASHG 2016, detailing the new QIAseq® cfDNA All-in-One Kit — including…

Sample to insight solutions for liquid biopsy, hereditary diseases, and RNA-seq Meet us at ASHG 2016 Together with leading scientists and…